Adaptive Biotechnologies Corp (ADPT) income statement
ADPTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$27.93−0.12 (-0.43%)
Close on Nov 20, 2026Market cap $4.46BP/E –Yield –
Adaptive Biotechnologies Corp financial ratios
See a number that looks wrong?